1. EU Health Priorities
Jurate Svarcaite
Secretary General PGEU

2. Pharmaceutical Group of European Union
Members: Professional Bodies & Pharmacists’ Associations
Austria
Belgium
Bulgaria
Croatia
Cyprus
Czech Rep
Denmark
Estonia
Finland
France
Germany
Greece
Hungary
Ireland
Italy
Luxembourg
Malta
Netherlands
Poland
Portugal
Romania
Slovakia
Slovenia
Spain
Sweden
United Kingdom
Bosnia Herzegovina
FYR Macedonia
Norway
Serbia
Switzerland
Turkey
Ukraine
2016: 33 Countries 2

3. Community Pharmacists citizens visit a pharmacy every day
1959
2016
Community Pharmacists
Pharmacies
46 million
citizens visit a pharmacy every day

4. Mission of PGEU
PGEU, as a a rigorous, proactive & constructive stakeholder:
Ensures our shared vision of Community Pharmacy is reflected in EU policy and legislative developments
Advocates for the contribution community pharmacists make to health systems and to public health through the provision of health services and the promotion of the rational and appropriate use of medicines
Promotes and develops cooperation in Community Pharmacy among the European nations

5. How do we do this?
Working collaboratively with members to establish positions that reflect the view of the profession as a whole in Europe
Establishing & maintaining working relationships with other European & International stakeholders
Dedicated Secretariat who are central to the organisation
Keeping patient care as the central focus

6. EU Health Law EU: complementary competence in health
Focus on Public Health (Art 168 TFEU): limited powers ‘towards improving health and preventing disease”
Legal competencies: standard blood (organ) products, organs, tissues and medicines
Respecting the MS responsibilities for organisation, delivery and financing of medical care

7. EU Single Market
Free movement:
People
Services
Goods
Capital

8. PGEU is involved in a number of legal dossiers…
Professional Recognition Directive
Falsified Medicines Directive
Medical Devices Regulation
Health Claims on Botanicals
Veterinary medicines
Trade Agreements
VAT
Waste Directive

9. Professional Qualifications Recognition Directive (I)

10. Professional Qualifications Recognition Directive (II)
The scope of pharmacist activities:
(a) preparation of the pharmaceutical form of medicinal products;
(b) manufacture and testing of medicinal products;
(c) testing of medicinal products in a laboratory for the testing of medicinal products;
(d) storage, preservation and distribution of medicinal products at the wholesale stage;
(e) supply, preparation, testing, storage, distribution and dispensing of safe and efficacious medicinal products of the required quality in pharmacies open to the public;
(f) preparation, testing, storage and dispensing of safe and efficacious medicinal products of the required quality in hospitals;
(g) provision of information and advice on medicinal products as such, including on their appropriate use;
(h) reporting of adverse reactions of pharmaceutical products to the competent authorities;
(i) personalised support for patients who administer their medication;
(j) contribution to local or national public health campaigns;

11. Digital single market

12. PGEU

14. AMR a major European challenge
Why is AMR a serious threat to society and economy?
patients die annually in the EU alone as a result of infections caused by resistant bacteria.
€1.5 billion euros each year extra healthcare costs and productivity losses due to multidrug-resistant bacteria in the EU.
The consumption of specific antibiotics used for treatment of multidrug-resistant bacterial infections has increased significantly between
Some good news - There has been a significant decrease in antibiotic consumption in the community in 5 countries (Denmark, Luxembourg, Slovenia, Spain and Sweden).

15. Source: http://ec. europa

16. Eurobarometer 2016
Source:

17. EAAD

18. National campaigns

19. THANK YOU